Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia. (Record no. 19407529)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02264 a2200625 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515201722.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201003s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1527-7755 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1200/JCO.2009.24.2008 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Schiller, Gary J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100304 |
245 00 - TITLE STATEMENT | |
Title | Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Date of publication, distribution, etc. | Feb 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 815-21 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Age Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents, Alkylating |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Comorbidity |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Europe |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Leukemic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Diseases |
General subdivision | mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hydrazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Karyotyping |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Liver Diseases |
General subdivision | mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Diseases |
General subdivision | mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Assessment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
General subdivision | epidemiology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | O'Brien, Susan M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pigneux, Arnaud |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deangelo, Daniel J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vey, Norbert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kell, Jonathan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Solomon, Scott |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stuart, Robert K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karsten, Verena |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cahill, Ann L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Albitar, Maher X |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Giles, Francis J |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
Related parts | vol. 28 |
-- | no. 5 |
-- | p. 815-21 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2009.24.2008">https://doi.org/10.1200/JCO.2009.24.2008</a> |
Public note | Available from publisher's website |
No items available.